← Leaderboards
Nansu Zong
Mayo Clinic Rochester
$855,333
Attributed
$855,333
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $257.3K · FY2020–23$500K$375K$250K$125K$0
'20
'21
'22
'23
Funding mix
By agency
NIH$855,333 · 2
By mechanism
R00$747,000 · 1
K99$108,333 · 1
Top collaborators
No co-investigators on record.
Most similar at Mayo Clinic Rochester
Same institution · by research overlap
- Jyotishman Pathak$11,987,741
- Guergana K. Savova$14,834,636
- Guoqian Jiang$4,499,950
- Gregory A Worrell$20,841,105
- Louis James Maher$21,515,136
Others in their field
Other Emerging Leaders on “Area”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Leonard Freedman · Leidos Biomedical Research, Inc.$164,467,481
Research focus
AreaBaseBase RatiosBenchmarkingBig DataBiomedical InformaticsCancer GenomicsClinicComputational BiologyComputer AssistedComputer Based Semantic AnalysisCostDatabasesData IntegrationData ManagementData SetData SourcesData ToolsDeep LearningDeep Neural NetworkDesignDimensionsDrug DevelopmentAlgorithms
Grant awards (5)
BOND: Benchmarking based on heterogeneous biOmedical Network and Deep learning novel drug-target associations$249,000
R00 · FY2023 · GM · contact PI
BOND: Benchmarking based on heterogeneous biOmedical Network and Deep learning novel drug-target associations$249,000
R00 · FY2022 · GM · contact PI
BOND: Benchmarking based on heterogeneous biOmedical Network and Deep learning novel drug-target associations$249,000
R00 · FY2021 · GM · contact PI
BOND: Benchmarking based on heterogeneous biOmedical Network and Deep learning novel drug-target associations$8,333
K99 · FY2021 · GM · contact PI
BOND: Benchmarking based on heterogeneous biOmedical Network and Deep learning novel drug-target associations$100,000
K99 · FY2020 · GM · contact PI